17 research outputs found

    Biases in Expansion Distances of Novae Arising from the Prolate Geometry of Nova Shells

    Get PDF
    (abridged) Expansion distances (or expansion parallaxes) for classical novae are based on comparing a measurement of the shell expansion velocity, multiplied by the time since outburst, with some measure of the angular size of the shell. We review and formalize this method in the case of prolate spheroidal shells. We present expressions for the maximum line-of-sight velocity from a complete, expanding shell and for its projected major and minor axes, in terms of the intrinsic axis ratio and the inclination of the polar axis to the line of sight. For six distinct definitions of ``angular size'', we tabulate the error in distance that is introduced under the assumption of spherical symmetry (i.e., without correcting for inclination and axis ratio). The errors can be significant and systematic, affecting studies of novae whether considered individually or statistically. Each of the six estimators overpredicts the distance when the polar axis is close to the line of sight, and most underpredict the distance when the polar axis is close to the plane of the sky. The straight mean of the projected semimajor and semiminor axes gives the least distance bias for an ensemble of randomly oriented prolate shells. The best individual expansion distances, however, result from a full spatio-kinematic modeling of the nova shell. We discuss several practical complications that affect expansion distance measurements of real nova shells. Nova shell expansion distances be based on velocity and angular size measurements made contemporaneously if possible, and the same ions and transitions should be used for the imaging and velocity measurements. We emphasize the need for complete and explicit reporting of measurement procedures and results, regardless of the specific method used.Comment: 21 pages, LaTeX, uses aasms4.sty, to be published in Publ. Astron. Soc. of the Pacific, May 200

    The Post-Common Envelope and Pre-Cataclysmic Binary PG 1224+309

    Get PDF
    We have made extensive spectroscopic and photometric observations of PG 1224+309, a close binary containing a DA white dwarf primary and an M4+ secondary. The H alpha line is in emission due to irradiation of the M-star by the hot white dwarf and is seen to vary around the orbit. From the radial velocities of the H alpha line we derive a period of P = 0.258689 +/- 0.000004 days and a semi-amplitude of K_Halpha = 160 +/- 8 km/s. We estimate a correction Delta_K = 21 +/- 2 km/s, where K_M = K_Halpha + Delta_K. Radial velocity variations of the white dwarf reveal a semi-amplitude of K_WD = 112 +/- 14 km/s. The blue spectrum of the white dwarf is well fit by a synthetic spectrum having T_eff = 29,300 K and log(g) = 7.38. The white dwarf contributes 97% of the light at 4500 Angstroms and virtually all of the light blueward of 3800 Angstroms. No eclipses are observed. The mass inferred for the white dwarf depends on the assumed mass of the thin residual hydrogen envelope: 0.40 < M_WD < 0.45 solar masses for hydrogen envelope masses of 0 < M_H < 4.0E-4 solar masses. We argue that the mass of the white dwarf is closer to 0.45 solar masses, hence it appears that the white dwarf has a relatively large residual hydrogen envelope. The mass of the M-star is then M_M = 0.28 +/- 0.05 solar masses, and the inclination is i = 77 +/- 7 degrees. We discuss briefly how PG 1224+309 may be used to constrain theories of close binary star evolution, and the past and future histories of PG 1224+309 itself. The star is both a ``post-common envelope'' star and a ``pre-cataclysmic binary'' star. Mass transfer by Roche-lobe overflow should commence in about 10 Gyr.Comment: 17 pages, 8 figures, AAS LaTeX, to appear in AJ, March 199

    Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial.

    Get PDF
    BACKGROUND: Staphylococcus aureus bacteraemia is a common cause of severe community-acquired and hospital-acquired infection worldwide. We tested the hypothesis that adjunctive rifampicin would reduce bacteriologically confirmed treatment failure or disease recurrence, or death, by enhancing early S aureus killing, sterilising infected foci and blood faster, and reducing risks of dissemination and metastatic infection. METHODS: In this multicentre, randomised, double-blind, placebo-controlled trial, adults (≥18 years) with S aureus bacteraemia who had received ≤96 h of active antibiotic therapy were recruited from 29 UK hospitals. Patients were randomly assigned (1:1) via a computer-generated sequential randomisation list to receive 2 weeks of adjunctive rifampicin (600 mg or 900 mg per day according to weight, oral or intravenous) versus identical placebo, together with standard antibiotic therapy. Randomisation was stratified by centre. Patients, investigators, and those caring for the patients were masked to group allocation. The primary outcome was time to bacteriologically confirmed treatment failure or disease recurrence, or death (all-cause), from randomisation to 12 weeks, adjudicated by an independent review committee masked to the treatment. Analysis was intention to treat. This trial was registered, number ISRCTN37666216, and is closed to new participants. FINDINGS: Between Dec 10, 2012, and Oct 25, 2016, 758 eligible participants were randomly assigned: 370 to rifampicin and 388 to placebo. 485 (64%) participants had community-acquired S aureus infections, and 132 (17%) had nosocomial S aureus infections. 47 (6%) had meticillin-resistant infections. 301 (40%) participants had an initial deep infection focus. Standard antibiotics were given for 29 (IQR 18-45) days; 619 (82%) participants received flucloxacillin. By week 12, 62 (17%) of participants who received rifampicin versus 71 (18%) who received placebo experienced treatment failure or disease recurrence, or died (absolute risk difference -1·4%, 95% CI -7·0 to 4·3; hazard ratio 0·96, 0·68-1·35, p=0·81). From randomisation to 12 weeks, no evidence of differences in serious (p=0·17) or grade 3-4 (p=0·36) adverse events were observed; however, 63 (17%) participants in the rifampicin group versus 39 (10%) in the placebo group had antibiotic or trial drug-modifying adverse events (p=0·004), and 24 (6%) versus six (2%) had drug interactions (p=0·0005). INTERPRETATION: Adjunctive rifampicin provided no overall benefit over standard antibiotic therapy in adults with S aureus bacteraemia. FUNDING: UK National Institute for Health Research Health Technology Assessment

    Effective student teams for collaborative learning in an introductory university physics course

    No full text
    We have studied the types of student teams that are most effective for collaborative learning in a large freshman university physics course. We compared teams in which the students were all of roughly equal ability to teams with a mix of student abilities, we compared teams with three members to teams with four members, and we examined teams with only one female student and the rest of the students male. We measured team effectiveness by the gains on the Force Concept Inventory and by performance on the final examination. None of the factors that we examined had significant impact on student learning. We also investigated student satisfaction as measured by responses to an anonymous evaluation at the end of the term, and found small but statistically significant differences depending on how the nine teams in the group were constructed

    Correlating student interest and high school preparation with learning and performance in an introductory university physics course

    No full text
    We have studied the correlation of student performance in a large first year university physics course with their reasons for taking the course and whether or not the student took a senior-level high school physics course. Performance was measured both by the Force Concept Inventory and by the grade on the final examination. Students who took the course primarily for their own interest outperformed students who took the course primarily because it was required, both on the Force Concept Inventory and on the final examination; students who took a senior-level high school physics course outperformed students who did not, also both on the Force Concept Inventory and on the final exam. Students who took the course for their own interest and took high school physics outperformed students who took the course because it was required and did not take high school physics by a wide margin. However, the normalized gain on the Force Concept Inventory was the same within uncertainties for all groups and subgroups of students

    Personality types and student performance in an introductory physics course

    No full text
    We measured the personality type of the students in a large introductory physics course of mostly life science students using the True Colors instrument. We found large correlations of personality type with performance on the precourse Force Concept Inventory (FCI), both term tests, the postcourse FCI, and the final examination. We also saw correlations with the normalized gain on the FCI. The personality profile of the students in this course is very different from the profile of the physics faculty and graduate students, and also very different from the profile of students taking the introductory physics course intended for physics majors and specialists
    corecore